Carlos Bernardes
Overview
Explore the profile of Carlos Bernardes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gamelas V, Canha I, Pimentel J, Santos S, Borges V, Bernardes C
GE Port J Gastroenterol
. 2022 Dec;
29(6):436-438.
PMID: 36545186
No abstract available.
2.
Simoes G, Borges V, Bernardes C, Ramos J
Inflamm Bowel Dis
. 2022 Nov;
29(1):e1-e2.
PMID: 36350976
No abstract available.
3.
Rocha M, Borges V, Simoes G, Santos S, Gamelas V, Bernardes C
GE Port J Gastroenterol
. 2020 Oct;
27(5):364-367.
PMID: 32999910
Introduction: Cytomegalovirus (CMV) is the most common opportunistic agent in HIV-infected patients. It can affect the entire gastrointestinal tract, but frequently involves the oesophagus and the colon. Case Report: We...
4.
Perez-Cuadrado-Robles E, Pinho R, Gonzalez B, Mao de Ferro S, Chagas C, Esteban Delgado P, et al.
GE Port J Gastroenterol
. 2020 Oct;
27(5):324-335.
PMID: 32999905
The present evidence-based guidelines are focused on the use of device-assisted enteroscopy in the management of small-bowel diseases. A panel of experts selected by the Spanish and Portuguese small bowel...
5.
Bernardes C
GE Port J Gastroenterol
. 2020 Oct;
27(5):299-301.
PMID: 32999900
No abstract available.
6.
Perez-Cuadrado Robles E, Pinho R, Gonzalez-Suarez B, Mao-de-Ferro S, Chagas C, Esteban Delgado P, et al.
Rev Esp Enferm Dig
. 2020 Mar;
112(4):309-318.
PMID: 32188259
The present evidence-based guidelines are focused on the use of device-assisted enteroscopy in the management of small-bowel diseases. A panel of experts selected by the Spanish and Portuguese small-bowel study...
7.
Santos S, Bernardes C, Borges V, Ramos G
Ann Hematol
. 2019 Nov;
99(2):367-369.
PMID: 31773212
No abstract available.
8.
Lymphoproliferative Disorders in Inflammatory Bowel Disease Patients: Is It the Drugs or the Disease
Bernardes C, Russo P, Carvalho D, Saiote J, Ramos J
GE Port J Gastroenterol
. 2018 Jul;
25(4):175-178.
PMID: 29998162
Introduction: Systemic inflammatory diseases are related to an increased risk of lymphoproliferative disorders. Although inflammatory bowel disease (IBD) was also associated with these conditions, population-based studies failed to demonstrate this...
9.
Bernardes C, Santos S, Loureiro R, Borges V, Ramos G
GE Port J Gastroenterol
. 2018 Apr;
25(2):91-95.
PMID: 29662934
Rendu-Osler-Weber disease, also known as hereditary hemorrhagic telangiectasia, is a rare autosomal dominant disorder which is often characterized by recurrent epistaxis, mucocutaneous and gastrointestinal telangiectasias, and visceral arteriovenous malformations. Patients...
10.
Carvalho D, Russo P, Bernardes C, Saiote J, Ramos G, Mascarenhas L, et al.
GE Port J Gastroenterol
. 2017 Dec;
24(6):279-284.
PMID: 29255769
Introduction: Lymphoproliferative disorders, particularly non-Hodgkin's and Hodgkin's lymphomas, are rare in patients with inflammatory bowel diseases. The use of thiopurines and infection by Epstein-Barr virus are well-known cofactors that can...